Merit Medical Net Income Over Time
| MM3 Stock | EUR 70.00 1.00 1.45% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Merit Medical Performance and Merit Medical Correlation. Merit |
Cross Equities Net Income Analysis
Compare Merit Medical Systems and related stocks such as Cerence, TELES Informationstech, and BIOTIME Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0S6 | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | (18.3 M) | 45.9 M | (310.8 M) | (56.3 M) | (588.1 M) | (18.7 M) | (16.8 M) | (17.7 M) |
| TLIK | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 3.1 M | 521 K | (3 M) | 3.9 M | 824.5 K | 267.5 K | (1.7 M) | (1.9 M) | (835.2 K) | (751.7 K) | (714.1 K) |
| BT3 | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | (20 M) | (46 M) | (11.7 M) | (20.6 M) | (43 M) | (26.3 M) | (21.5 M) | (18.6 M) | (16.7 M) | (17.6 M) |
| MS9 | (487 B) | (487 B) | (487 B) | (487 B) | (155 B) | (758.1 B) | (197.4 B) | (289.3 B) | (228.1 B) | (75.3 B) | (200.1 B) | (181.9 B) | (244.7 B) | (274.8 B) | (116.7 B) | (134.2 B) | (140.9 B) |
| IB5A | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (312.8 M) | (362.8 M) | (455.6 M) | (397 M) | (275.4 M) | (363.7 M) | (885.7 M) | (589.3 M) | (553.3 M) | (498 M) | (522.9 M) |
| MBJ | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (1.6 B) | (296 M) | (359 M) | (578 M) | (445 M) | (203 M) | (487 M) | (444 M) | (510.6 M) | (536.1 M) |
| MBJ | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (338 M) | (1.6 B) | (296 M) | (359 M) | (578 M) | (445 M) | (203 M) | (487 M) | (444 M) | (510.6 M) | (536.1 M) |
| TZO | (778 K) | (778 K) | (778 K) | (778 K) | (1 M) | (9.6 M) | (2.2 M) | (1.3 M) | (1 M) | (297.6 K) | (654.9 K) | (1.3 M) | (2 M) | (1.2 M) | (1 M) | (1.2 M) | (1.3 M) |
| AJW | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (3.8 B) | (3 B) | (3.8 B) | (4.2 B) | (13.7 B) | (14.7 B) | (7.4 B) | (28.1 B) | (25.3 B) | (24.1 B) |
| 9R5 | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (19.2 M) | (12.2 M) | (10.2 M) | (9.2 M) | (9.6 M) |
Merit Medical Systems and related stocks such as Cerence, TELES Informationstech, and BIOTIME Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Merit Medical Systems financial statement analysis. It represents the amount of money remaining after all of Merit Medical Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Merit Medical Systems | MM3 |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 1600 West Merit |
| Exchange | Frankfurt Exchange |
EUR 70.0
Check out Merit Medical Performance and Merit Medical Correlation. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Merit Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.